Can Thailand Actually Export Cannabis to Europe?

Thailand cannot currently export cannabis to Europe at any meaningful scale, and the reason is not cultivation capacity. It is certification. To supply the European medical market, a producer needs EU-GMP certification, and a database check confirms Thailand holds effectively none for cannabis finished products. Until that changes, the European opportunity that features in so many pitch decks is closed, no matter how much Thailand grows.

The certification wall

EU-GMP is the manufacturing standard required to sell medical cannabis into the European Union. It is demanding, expensive, and slow to obtain. A live check of the relevant European databases shows no cannabis finished-product EU-GMP certifications for Thailand. That single fact, not tariffs or demand, is what closes the door.

Why cultivation capacity is irrelevant here

The export narrative usually leads with how much Thailand can grow. But growing capacity does not clear a regulatory wall. A market that requires EU-GMP does not open because supply exists; it opens when supply is certified. Confusing capacity with market access is the central error in the bullish export story.

What it would take to change

Closing the gap requires producers to invest in achieving EU-GMP certification, which is a multi-year, capital-intensive process that few have pursued. Until a meaningful number of Thai facilities clear that bar, large-scale legal export to Europe remains aspirational. Anyone evaluating an export play should start with the certification count, not the cultivation figures.